Division of Allergy and Immunology Patient Stories
1 - 10 of 28
X-linked Lymphoproliferative Disease 1: Rafi’s Story
Genetic sequencing revealed that Rafi had an extremely rare, often fatal disease — and the discovery was amazingly made before he had serious symptoms.
Eosinophilic Esophagitis: Princess’ story
Princess has struggled for years with a rare inflammatory condition of the esophagus. Thanks to CHOP, a new medication and family support, she’s now thriving.
Food Allergies and OIT: Rani’s Story
Oral immunotherapy helps 12-year-old Rani achieve new-found freedom and confidence from multiple food allergies that have plagued her since infancy.
New Genetic Condition Identified: Luke’s Story
Luke’s repeated infections worried his parents and puzzled his doctors. Whole-exome sequencing helped CHOP researchers discover a new genetic disease causing his symptoms and determine the best course of treatment.
Hypogammaglobulinemia: Dylan’s Story
Looking for bright spot during COVID-19? Look no further than 7-year-old Dylan, an active 2nd grader who’s had his first infection-free year in his entire life.
Learning to Live With Food Allergies: Dominic's Story
CHOP's Food Allergy Bravery Clinic helps children retake control of their lives, their food allergies and their mental health.
Food Allergies: Grace's Story
Plagued with food allergies for years, 12-year-old Grace can now eat almost anything thanks to a breakthrough oral immunotherapy program at CHOP.
Food Intolerance: Oliver’s Story
No more skipping treats for Oliver, thanks to the Food Reactions Clinic at Children’s Hospital of Philadelphia (CHOP).
New Oral Immunotherapy Treatment for Peanut Allergy: Noah's Story
With help from a new FDA-approved oral immunotherapy (OIT) treatment, Noah can now experience life without fear of adverse reactions from peanut protein.
Peanut Allergy: Addison's Story
Addison’s peanut allergy has improved greatly thanks to a promising new treatment at CHOP. The 12-year-old has shown her thanks by raising money to help more kids like her.